Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Bolz: Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment. (0.15 sec) 

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment

- prsjournal.com
M Bolz, S Michels, W Geitzenauer, F Prager, U … - British Medical …, 2007 - bjo.bmj.com
Methods: Nine patients (nine eyes) received three systemic bevacizumab treatments at 2 week
intervals and were examined at baseline, weeks 1, 2, 4, 6 and month 3 by using optical coherence
tomography (Stratus OCT TM , Carl Zeiss© Meditec, Dublin, California, USA). Changes in ...
Cited by 15 - Related articles - BL Direct - All 5 versions

Combined photodynamic therapy and intravitreal triamcinolone acetonide injection …


R Axer-Siegel, R Ehrlich, I Avisar, M Kramer, I … - … surgery, lasers & … - ncbi.nlm.nih.gov
BACKGROUND AND OBJECTIVE: To report the outcome of combined verteporfin photodynamic
therapy (PDT) and intravitreal triamcinolone acetonide (IVTA) for the treatment of choroidal neovascularization
(CNV) with serous pigment epithelium detachment (PED) due to age-related macular ...
Cited by 10 - Related articles - BL Direct - All 3 versions

Does “Off-Label” Mean Off Limits for Patient Care?


R Parrish, P Sternberg - American Journal of Ophthalmology, 2007 - Elsevier
Gary Novack, PhD, an ocular pharmacologist (PharamaLogic Development, Inc, San Rafael,
California, USA) succinctly summarizes the development of off-label use in ophthalmology: “In
the US, we have an amphoteric approach to off-label use of pharmaceuticals. Physicians ...
Cited by 5 - Related articles - All 11 versions

[CITATION] Off label use-Arzneimittelrechtliche, haftungsrechtliche, berufsrechtliche und …


R Francke, D Hart - Die Sozialgerichtsbarkeit, 2003
Cited by 7 - Related articles

Repeated intravitreal injection of triamcinolone for exudative age-related macular …


JB Jonas, UH Spandau, BA Kamppeter, U … - Ophthalmic …, 2006 - content.karger.com
Background: Intravitreal triamcinolone acetonide has been discussed as treatment for exudative
age-related macular degeneration (AMD). Objectives: To give an updated report on repeated
intravitreal injections of triamcinolone acetonide (IVTA) for the treatment of exudative ...
Cited by 8 - Related articles - BL Direct - All 5 versions

Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation …


M Voelker, F Gelisken, F Ziemssen, J Wachtlin, S … - Graefe's Archive for …, 2005 - Springer
Abstract Purpose: To report the results of verteporfin photodynamic therapy (PDT) of extrafoveal
predominantly classic choroidal neovascularisation (CNV) secondary to age-related macular
degeneration (AMD). Methods: In this retro- spective study 20 consecutive patients (20 ...
Cited by 8 - Related articles - BL Direct - All 3 versions

Macular atrophy after combined intravitreal triamcinolone acetonide (IVTA) and …


FK Sutter, MM Kurz-Levin, J Fleischhauer, … - Klin Monatsbl …, 2006 - thieme-connect.com
Hintergrund: Retinale Angiomatöse Proliferation ist eine Unterform der neovaskulären AMD,
welche schlecht auf eine Standard PDT anzusprechen scheint. Diese Pilotstudie untersucht
die Wirksamkeit und Sicherheit einer kombinierten Behandlung mit intravitrealem ...
Cited by 9 - Related articles - BL Direct - All 3 versions

Duration of the effect of intravitreal triamcinolone acetonide in eyes with exudative …


JB Jonas, UHM Spandau, BA Kamppeter, RF … - Journal of Ocular …, 2006 - liebertonline.com
Page 1. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS Volume 22,
Number 3, 2006 © Mary Ann Liebert, Inc. Duration of the Effect of Intravitreal Triamcinolone
Acetonide in Eyes with Exudative Age-Related Macular Degeneration ...
Cited by 9 - Related articles - BL Direct - All 5 versions

[CITATION] Acute retinal pigment epithelial tear in the untreated fellow eye following repeated …


S Mennel, J Callizo, JC Schmidt, CH … - Acta Ophthalmologica …, 2007 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 17 - Related articles - BL Direct - All 4 versions

Intravitreal bevacizumab for refractory pigment epithelial detachment with occult …


E Chen, RS KAISER, JF VANDER - Retina, 2007 - journals.lww.com
Purpose: New medications targeting vascular endothelial growth factor show promise in the
treatment of wet macular degeneration. This study describes the clinical response and optical
coherence tomography (OCT) findings for patients with refractory pigment epithelial ...
Cited by 18 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google